Basit öğe kaydını göster

Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial

dc.contributor.authorLIN, Chinjune
dc.contributor.authorOzguroglu, Mustafa
dc.contributor.authorRIDOLFI, Antonia
dc.contributor.authorCARDOSO, Fatima
dc.contributor.authorRoyce, Melanie
dc.contributor.authorBACHELOT, Thomas
dc.contributor.authorVILLANUEVA, Cristian
dc.contributor.authorAZEVEDO, Sergio J.
dc.contributor.authorCRUZ, Felipe Melo
dc.contributor.authorDEBLED, Marc
dc.contributor.authorHegg, Roberto
dc.contributor.authorTOYAMA, Tatsuya
dc.contributor.authorFALKSON, Carla
dc.contributor.authorJEONG, Joon
dc.contributor.authorSRIMUNINNIMIT, Vichien
dc.contributor.authorGradishar, William J.
dc.contributor.authorARCE, Christina
dc.date.accessioned2021-03-03T16:23:33Z
dc.date.available2021-03-03T16:23:33Z
dc.date.issued2018
dc.identifier.citationRoyce M., BACHELOT T., VILLANUEVA C., Ozguroglu M., AZEVEDO S. J. , CRUZ F. M. , DEBLED M., Hegg R., TOYAMA T., FALKSON C., et al., "Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial", JAMA ONCOLOGY, cilt.4, sa.7, ss.977-984, 2018
dc.identifier.issn2374-2437
dc.identifier.othervv_1032021
dc.identifier.otherav_43fd4fd7-c0fe-4764-b07e-3a26b7970fe9
dc.identifier.urihttp://hdl.handle.net/20.500.12627/49403
dc.identifier.urihttps://doi.org/10.1001/jamaoncol.2018.0060
dc.description.abstractIMPORTANCE Cotargeting the mammalian target of rapamycin pathway and estrogen receptor may prevent or delay endocrine resistance in patients receiving first-line treatment for advanced breast cancer.
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectONKOLOJİ
dc.titleEverolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial
dc.typeMakale
dc.relation.journalJAMA ONCOLOGY
dc.contributor.departmentUNICANCER , ,
dc.identifier.volume4
dc.identifier.issue7
dc.identifier.startpage977
dc.identifier.endpage984
dc.contributor.firstauthorID44286


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster